TFF Pharmaceuticals, Inc.

NasdaqCM:TFFP Stok Raporu

Piyasa değeri: US$6.8m

TFF Pharmaceuticals Gelecekteki Büyüme

Future kriter kontrolleri 2/6

TFF Pharmaceuticals is forecast to grow earnings and revenue by 55.9% and 73.2% per annum respectively while EPS is expected to grow by 58.5% per annum.

Anahtar bilgiler

55.9%

Kazanç büyüme oranı

58.5%

EPS büyüme oranı

Pharmaceuticals kazanç büyümesi23.7%
Gelir büyüme oranı73.2%
Gelecekteki özkaynak getirisin/a
Analist kapsamı

Low

Son güncelleme26 Sep 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Can TFF Pharmaceuticals (NASDAQ:TFFP) Afford To Invest In Growth?

Apr 10
Can TFF Pharmaceuticals (NASDAQ:TFFP) Afford To Invest In Growth?

Is TFF Pharmaceuticals (NASDAQ:TFFP) In A Good Position To Deliver On Growth Plans?

Sep 27
Is TFF Pharmaceuticals (NASDAQ:TFFP) In A Good Position To Deliver On Growth Plans?

TFF Pharma: The Potential Is Still Very Much Present

Aug 29

TFF Pharmaceuticals: Q3 Data Is Pivotal In So Many Ways

Aug 09

TFF Pharmaceuticals expands R&D operations with new Austin facility

Jul 14

TFF Pharmaceuticals: A Highly Attractive Basket Of Options

May 23

We Think TFF Pharmaceuticals (NASDAQ:TFFP) Needs To Drive Business Growth Carefully

May 17
We Think TFF Pharmaceuticals (NASDAQ:TFFP) Needs To Drive Business Growth Carefully

Here's Why We're Not Too Worried About TFF Pharmaceuticals' (NASDAQ:TFFP) Cash Burn Situation

Jan 06
Here's Why We're Not Too Worried About TFF Pharmaceuticals' (NASDAQ:TFFP) Cash Burn Situation

TFF Pharmaceuticals: Upside Catalysts Starting To Show Up Amid Omicron, But Timidly

Dec 02

Kazanç ve Gelir Büyüme Tahminleri

NasdaqCM:TFFP - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/202612-20N/AN/A1
12/31/20251-26N/AN/A1
12/31/20241-20N/AN/A1
6/30/20241-19-14-14N/A
3/31/20241-20-15-15N/A
12/31/20231-21-16-16N/A
9/30/20231-24-20-20N/A
6/30/20231-27-25-24N/A
3/31/20230-30-26-24N/A
12/31/20220-32-29-27N/A
9/30/20220-34-32-31N/A
6/30/20220-36-31-30N/A
3/31/20220-32-32-31N/A
12/31/20210-31-30-30N/A
9/30/20210-27-26-25N/A
6/30/20210-23-24-22N/A
3/31/20210-22-21-20N/A
12/31/2020N/A-19-18-17N/A
9/30/2020N/A-41-15-15N/A
6/30/2020N/A-39-14-14N/A
3/31/2020N/A-38-11-11N/A
12/31/2019N/A-37-11-11N/A
9/30/2019N/A-9-8-8N/A
6/30/2019N/A-7-5-5N/A
3/31/2019N/A-7-4-4N/A
12/31/2018N/A-5-2-2N/A
9/30/2018N/A-4-1-1N/A
6/30/2018N/A-3-1-1N/A
3/31/2018N/A0N/A0N/A
12/31/2017N/A0N/A0N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: TFFP is forecast to remain unprofitable over the next 3 years.

Kazançlar ve Piyasa: TFFP is forecast to remain unprofitable over the next 3 years.

Yüksek Büyüme Kazançları: TFFP is forecast to remain unprofitable over the next 3 years.

Gelir ve Pazar: TFFP's revenue (73.2% per year) is forecast to grow faster than the US market (8.9% per year).

Yüksek Büyüme Geliri: TFFP's revenue (73.2% per year) is forecast to grow faster than 20% per year.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: Insufficient data to determine if TFFP's Return on Equity is forecast to be high in 3 years time


Büyüyen şirketleri keşfedin